Cellosaurus A375 PLX/AZD-resistant (CVCL_C0Q6)
| Cell line name | A375 PLX/AZD-resistant |
|---|---|
| Accession | CVCL_C0Q6 |
| Resource Identification Initiative | To cite this cell line use: A375 PLX/AZD-resistant (RRID:CVCL_C0Q6) |
| Comments | Population: Caucasian. Characteristics: Established by growing the parent cell line in an increasing concentration PLX4032 and AZD6244 up to a concentration of 1 microMolar (PubMed=35128241). Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032). Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244). Omics: Proteomics; Quantitative. Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511. |
| Sequence variations |
|
| Disease | Amelanotic melanoma (NCIt: C3802) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0132 (A-375) |
| Sex of cell | Female |
| Age at sampling | 54Y |
| Category | Cancer cell line |
| Publications | PubMed=35128241; DOI=10.1021/acsomega.1c05361; PMCID=PMC8811929 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_C0Q6 |
| Encyclopedic resources | Wikidata; Q112927056 |
| Proteomic databases | PRIDE; PXD026952 |
| Entry history | |
| Entry creation | 23-Jun-2022 |
| Last entry update | 27-Nov-2025 |
| Version number | 9 |